1. Home
  2. WABC vs COLL Comparison

WABC vs COLL Comparison

Compare WABC & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westamerica Bancorporation

WABC

Westamerica Bancorporation

N/A

Current Price

$59.99

Market Cap

1.4B

Sector

Finance

ML Signal

N/A

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

N/A

Current Price

$24.14

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WABC
COLL
Founded
1972
2002
Country
United States
United States
Employees
627
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
WABC
COLL
Price
$59.99
$24.14
Analyst Decision
Hold
Buy
Analyst Count
2
8
Target Price
★ $65.00
$49.00
AVG Volume (30 Days)
154.4K
★ 592.2K
Earning Date
10-15-2026
11-05-2026
Dividend Yield
★ 3.21%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 3.40
0.64
Revenue
N/A
★ $780,567,000.00
Revenue This Year
N/A
$6.73
Revenue Next Year
$1.81
$1.37
P/E Ratio
★ $18.02
$36.98
Revenue Growth
N/A
N/A
52 Week Low
$46.23
$21.43
52 Week High
$63.61
$50.79

Technical Indicators

Market Signals
Indicator
WABC
COLL
Relative Strength Index (RSI) 47.04 59.34
Support Level $57.73 $21.67
Resistance Level $60.76 $35.89
Average True Range (ATR) 1.30 0.89
MACD -0.18 0.22
Stochastic Oscillator 15.73 54.47

Price Performance

Historical Comparison
WABC
COLL

About WABC Westamerica Bancorporation

Westamerica Bancorp provides a full range of banking services to individual and commercial customers in Northern and Central California through its subsidiary bank. The Bank is a California-chartered commercial bank whose deposits are insured by the Federal Deposit Insurance Corporation (the FDIC) up to applicable limits. The principal communities served are located in Northern and Central California, from Mendocino, Lake and Nevada Counties in the north to Kern County in the south. The Company's strategic focus is on the banking needs of small businesses.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: